HomeCONGRESSInternational Congresses

International Congresses

View Category
HIGHLIGHTS

CANTOS: Anti-inflammatory Drug Canakinumab Seems to Reduce CV Events

This human monoclonal antibody that specifically targets inflammatory cells seems to reduce cardiovascular events when associated with...
solaci -
Learn More
Acute coronary syndromes

VALIDATE-SWEDEHEART: bivalirudin seems to be losing ground

Another important work that does not see the benefits of bivalirudin over heparin as monotherapy as regards both...
solaci -
Learn More
HIGHLIGHTS

SPYRAL HTN-OFF MED: Renal Denervation Reloaded?

This work presented at the ESC Congress 2017 held in Barcelona, simultaneously published in The Lancet, seems to...
solaci -
Learn More
Antithrombotic Anticoagulants

RE-DUAL PCI: Anti-Thrombotic Management in Patients with Atrial Fibrillation and PCI

RE-DUAL PCI outcomes have been published by the  New England Journal of Medicine along with their presentation at...
solaci -
Learn More
ESC 2017

ESC 2017

Here you will find the highlights of ESC 2017, held on August 26-30 in Barcelona, Spain. If you cannot view...
solaci -
Learn More
Institutional News

SOLACI symposium at EURO PCR 2017

The Latin American Society of Interventional Cardiology proudly joined the international meeting “Euro PCR 2017”, celebrated on...
solaci -
Learn More
Coronary disease

EuroCTO: Rechanneling vs. Optimal Medical Treatment in Total Occlusions

Courtesy of the SBHCI. Chronic total occlusions represent around 18% of all coronary lesions. However, they account for...
solaci -
Learn More
DAY 3

COMPARE-ACUTE: FFR-Guided Non-Culprit Vessel Revascularization in Primary Angioplasty

Courtesy of the SBHCI. About 50% of patients admitted with acute ST-segment elevation myocardial infarction also present lesions...
solaci -
Learn More